EE423 The Cost Savings Potential Associated with the Use of Nefecon for Adults with Primary IgA Nephropathy in the United States

Abstract

Authors

M. Yaghoubi H. Jiang R. Casciano C. Ngai M. Patel

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×